Vienne, France

Eric Jean-Luc Perrier

This inventor holds 1 USPTO granted patent. Top assignee: Coletica. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eric Jean-Luc Perrier: Innovator in Nanotechnology

Introduction

Eric Jean-Luc Perrier is a notable inventor based in Vienne, France. He has made significant contributions to the field of nanotechnology, particularly in the development of innovative methods for producing nanocapsules. His work has implications in various industries, including cosmetics, pharmaceuticals, and food.

Latest Patents

Eric Jean-Luc Perrier holds a patent for a method for producing nanocapsules with cross-linked protein-based walls. This patent describes a process that involves preparing emulsions of proteins and crosslinking them with a reactive crosslinking agent. The resulting biocompatible and biodegradable nanocapsules exhibit improved controlled release properties, making them valuable for various applications.

Career Highlights

Throughout his career, Perrier has focused on advancing the science of nanotechnology. His innovative approach to creating nanocapsules has positioned him as a leader in this emerging field. He is currently associated with Coletica, where he continues to explore new applications for his inventions.

Collaborations

Eric Jean-Luc Perrier has collaborated with Alain Roger Huc, contributing to the advancement of their shared research interests. Their partnership has fostered innovation and development in the field of nanotechnology.

Conclusion

Eric Jean-Luc Perrier's work in nanotechnology exemplifies the potential of innovative methods in producing advanced materials. His contributions are paving the way for new applications in various industries, showcasing the importance of research and development in this field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…